Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis
出版年份 2018 全文链接
标题
Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis
作者
关键词
-
出版物
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 62, Issue 7, Pages e00636-18
出版商
American Society for Microbiology
发表日期
2018-05-04
DOI
10.1128/aac.00636-18
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries
- (2018) A. Trébucq et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Varying effects of common tuberculosis drugs on enhancing clofazimine activity in vitro
- (2017) Shuo Zhang et al. Emerging Microbes & Infections
- Mutations inpepQConfer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis
- (2016) Deepak Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy
- (2016) Rosemary V. Swanson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis
- (2016) Giovanni Sotgiu et al. EUROPEAN RESPIRATORY JOURNAL
- Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo
- (2016) Weijie Zhao et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Clofazimine has delayed antimicrobial activity againstMycobacterium tuberculosisbothin vitroandin vivo
- (2016) Nicole C. Ammerman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activation of type II NADH dehydrogenase by quinolinequinones mediates antitubercular cell death
- (2016) Adam Heikal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters
- (2016) Lindsey H.M. te Brake et al. TUBERCULOSIS
- Turning the respiratory flexibility of Mycobacterium tuberculosis against itself
- (2016) Dirk A. Lamprecht et al. Nature Communications
- Ergothioneine Maintains Redox and Bioenergetic Homeostasis Essential for Drug Susceptibility and Virulence of Mycobacterium tuberculosis
- (2016) Vikram Saini et al. Cell Reports
- Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice
- (2016) Scott M. Irwin et al. ACS Infectious Diseases
- Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline
- (2015) Andreas H. Diacon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis
- (2015) Jean-Philippe Lanoix et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction
- (2015) Maxwell T. Chirehwa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum
- (2015) Jean-Philippe Lanoix et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosis
- (2015) Benoit Lechartier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Clofazimine in a Mouse Model of Tuberculosis
- (2015) Rosemary V. Swanson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Breast Mass in a 45-Year-Old Man
- (2015) L. Tang et al. CLINICAL INFECTIOUS DISEASES
- High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon
- (2015) C. Kuaban et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Bactericidal mode of action of bedaquiline
- (2015) K. Hards et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The association between sterilizing activity and drug distribution into tuberculosis lesions
- (2015) Brendan Prideaux et al. NATURE MEDICINE
- Antiinfectives targeting enzymes and the proton motive force
- (2015) Xinxin Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis
- (2015) Sandeep Tyagi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparative Study of the Effects of Antituberculosis Drugs and Antiretroviral Drugs on Cytochrome P450 3A4 and P-Glycoprotein
- (2014) Yasuhiro Horita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Limited Activity of Clofazimine as a Single Drug in a Mouse Model of Tuberculosis Exhibiting Caseous Necrotic Granulomas
- (2014) Scott M. Irwin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of the Nitroimidazoles PA-824 and TBA-354 to the Activity of Novel Regimens in Murine Models of Tuberculosis
- (2014) Rokeya Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses
- (2014) A. Piubello et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies
- (2014) Thomas J Hwang et al. BMJ Open
- Assessment of Clofazimine Activity in a Second-Line Regimen for Tuberculosis in Mice
- (2013) Jacques H. Grosset et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of repeated dosing on rifampin exposure in BALB/c mice
- (2013) Vinayak Hosagrahara et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Cost-effectiveness of novel first-line treatment regimens for tuberculosis
- (2013) J. P. Owens et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- The Pharmacokinetics and Pharmacodynamics of PulmonaryMycobacterium aviumComplex Disease Treatment
- (2012) Jakko van Ingen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis
- (2012) Kathy Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Coadministration of Moxifloxacin and Rifampin on Mycobacterium tuberculosis in a Murine Aerosol Infection Model
- (2012) V. Balasubramanian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Semimechanistic Pharmacokinetic-Enzyme Turnover Model for Rifampin Autoinduction in Adult Tuberculosis Patients
- (2012) Wynand Smythe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
- (2012) Andreas H Diacon et al. LANCET
- Clofazimine Analogs with Efficacy against Experimental Tuberculosis and Reduced Potential for Accumulation
- (2011) Yu Lu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pyrazinoic Acid Decreases the Proton Motive Force, Respiratory ATP Synthesis Activity, and Cellular ATP Levels
- (2011) Ping Lu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis
- (2011) Rokeya Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
- (2011) J. van Ingen et al. CLINICAL INFECTIOUS DISEASES
- Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
- (2010) Armand Van Deun et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Reduction of Clofazimine by Mycobacterial Type 2 NADH:Quinone Oxidoreductase
- (2010) Takahiro Yano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Patients' Costs and Cost-Effectiveness of Tuberculosis Treatment in DOTS and Non-DOTS Facilities in Rio de Janeiro, Brazil
- (2010) Ricardo Steffen et al. PLoS One
- Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis
- (2009) Murad Ibrahim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis
- (2009) D. Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started